Colorado enrolls first patient in clinical trial of HDAC inhibitor, OKI-179

IMAGE: This is Jennifer Diamond, MD, primary investigator of OKI-179 clinical trial. view more  Credit: University of Colorado Cancer Center OnKure, Inc. and the University of Colorado Cancer Center today announced enrollment of the first patient in a first-in-human phase 1 clinical trial testing investigational anti-cancer agent OKI-179, a novel and Class-selective HDAC inhibitor, in patients…

Details

Biting backfire: Some mosquitoes actually benefit from pesticide application

IMAGE: This is a predatory damselfly from the bromeliads. view more  Credit: Jennifer Weathered/Utah State University The common perception that pesticides reduce or eliminate target insect species may not always hold. Jennifer Weathered and Edd Hammill report that the impacts of agricultural pesticides on assemblages of aquatic insects varied resulting in distinct ecological winners and losers…

Details

Tanning industry uses promos, cheap prices to lure adolescents and young adults

Everyone knows cigarette smoking causes cancer and as a result, prices and advertising are closely regulated to discourage youth from starting. But another cancer risk, indoor tanning, which has been shown to cause melanoma, lags in regulation. Researchers at the Colorado School of Public Health have found that the tanning industry uses marketing strategies that…

Details

Lumping all Hispanic Americans together masks the differences in cancer outcomes

IMAGE: SDSU public health researchers Caroline Thompson and Steven Zamora studied cancer mortality statistics by separating out data for each Hispanic American ethnic group. view more  Credit: San Diego State University A San Diego State University study is among the first to describe trends in cancer mortality by specific Hispanic group for the 10 leading causes…

Details